# Valeska Schroeder

> Valeska Schroeder, Ph.D., is CEO and Chairman of the Board at Cerapedics Inc., the Colorado-based orthobiologics company behind i-FACTOR and PearlMatrix - two of only three FDA PMA-approved bone grafts on the U.S. spine market. A materials scientist by training (BS, MS, PhD from UC Berkeley), she spent the first part of her career in medtech product development before transitioning to venture investing at KCK MedTech, where she led deals and sat on boards of companies including Sight Sciences, Aerin Medical, Intuity Medical, and Lungpacer. She joined Cerapedics' board in 2018, deepened her involvement in 2021, and took the helm as CEO in November 2022, steering the company through PearlMatrix's landmark FDA approval in June 2025 - making Cerapedics the only company with two PMA-approved spinal biologics.

- **Role:** Chief Executive Officer and Chairman of the Board at Cerapedics Inc.
- **Organizations:** Cerapedics Inc., KCK MedTech, Sight Sciences, Aerin Medical, Intuity Medical, Lungpacer
- **Nationality:** American
- **Education:** BS in Materials Science and Engineering, University of California, Berkeley, MS in Materials Science and Engineering, University of California, Berkeley, PhD in Materials Science and Engineering, University of California, Berkeley
- **Known for:** Led Cerapedics to become the only company with two FDA PMA-approved spinal biologics (i-FACTOR for cervical fusion and PearlMatrix for lumbar fusion), Oversaw FDA approval of PearlMatrix P-15 Peptide Enhanced Bone Graft in June 2025 - the first and only proven bone growth accelerator for lumbar fusion, Secured expanded indications for PearlMatrix in January 2026, adding ALIF, PLIF, OLIF, and LLIF approaches

## Career timeline

- **pre-2016** — Held senior roles in product development, program management, and marketing at various medical device companies
- **2016** — Joined KCK MedTech as part of the Medical Technologies Investment Group, eventually becoming Managing Director
- **2018** — Joined Cerapedics board of directors when KCK invested in the company
- **2021** — Appointed Chairman of the Cerapedics Board of Directors; deepened operational involvement
- **2022-11** — Appointed Chief Executive Officer of Cerapedics, effective November 1, 2022
- **2025-06** — FDA granted PMA approval for PearlMatrix P-15 Peptide Enhanced Bone Graft for lumbar fusion - making Cerapedics the only company with two PMA-approved spinal biologics
- **2026-01** — FDA approved expanded indications for PearlMatrix to include ALIF, PLIF, OLIF, and LLIF in addition to TLIF
- **2026** — Cerapedics announced Vizient supplier agreement, reaching 65%+ of U.S. acute care providers

## Achievements

- Led Cerapedics to become the only company with two FDA PMA-approved spinal biologics (i-FACTOR for cervical fusion and PearlMatrix for lumbar fusion)
- Oversaw FDA approval of PearlMatrix P-15 Peptide Enhanced Bone Graft in June 2025 - the first and only proven bone growth accelerator for lumbar fusion
- Secured expanded indications for PearlMatrix in January 2026, adding ALIF, PLIF, OLIF, and LLIF approaches
- Closed Vizient supplier agreement providing access to 65%+ of acute care providers including 97% of academic medical centers
- Stewarded commercial expansion treating 150,000+ patients worldwide with P-15 peptide technology
- Served on boards of multiple KCK MedTech portfolio companies including Sight Sciences, Aerin Medical, Intuity Medical, and Lungpacer
- Earned BS, MS, and PhD in Materials Science and Engineering from UC Berkeley
- Oversaw headquarters expansion in Westminster, Colorado to support product growth

## Latest updates

- **2026-01** — FDA approved expanded indications for PearlMatrix to include multiple additional lumbar fusion approaches (ALIF, PLIF, OLIF, LLIF)
- **2025-10** — Cerapedics announced Vizient supplier agreement for PearlMatrix, expanding hospital reach to 65%+ of U.S. acute care providers
- **2025-06** — FDA granted PMA approval for PearlMatrix P-15 Peptide Enhanced Bone Graft for lumbar TLIF - first and only proven bone growth accelerator for lumbar fusion
- **2024-07** — Featured in BONEZONE magazine interview discussing spine market opportunities, supporting women in medtech leadership, and personal interests including the outdoors

## Links

- Website: https://cerapedics.com
- LinkedIn: http://www.linkedin.com/in/valeska-schroeder-1544284
- Twitter/X: https://twitter.com/CerapedicsInc
- Facebook: https://facebook.com/Cerapedics/

---

Profile page: https://yespress.io/valeska-schroeder
Published by YesPress — https://yespress.io
Last updated: 2026-05-11